A new study from Yale University has provided fresh insights into what causes DNA changes that lead to cancer. The research ...

Chekuri, V. and Trotter, G. (2025) Case Report: A Diagnostic Odyssey Unveiling BCGosis in an Elderly Patient. Case Reports in ...

Canine and human cancers bear many similarities, and studies on dogs are helping advance care for our furry friends and for ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...

AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

The Oxford, England-based biotechnology company develops medical tests. It described its EpiSwitch biomarkers as "an effective liquid biopsy method" meaning they can analyse blood samples. EpiSwitch ...

The broadcaster, 67, announced his diagnosis with stage four prostate cancer in June, saying he was ‘responding positively’ to treatment.

US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.